- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05522530
Cross-cultural Adaptation and Validity of Mini Bestest in Balance Disorders in the Autonomous City of Buenos Aires: Validation Study Protocol
August 28, 2022 updated by: Marcos Ceferino Gabriel Valdez, Hospital de Rehabilitacion Manuel Rocca
Cross-cultural Adaptation, Reliability, Validity and Viability of the Mini Bestest in Balance Disorders Upon Admission or Readmission to Vestibular Rehabilitation in the Autonomous City of Buenos Aires: Validation Study Protocol
The objective of this study is to carry out the cross-cultural adaptation of the Mini BESTest (a balance assessment scale) into Argentine Spanish, as well as to study its validation in patients with peripheral vestibular disorders in the autonomous city of Buenos Aires.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Autonomous City Of Buenos Aires
-
Almagro, Autonomous City Of Buenos Aires, Argentina, 1212
- Marcos Ceferino Gabriel Valdez
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
People with peripheral vestibular disorders
Description
Inclusion Criteria:
- Subjects >18 years of age,
- With vestibular alterations of peripheral etiology, within the second year of evolution
- Time of evolution of symptoms ≤ 2 years
- Independent walking with or without walking assistance device
- Who are at the beginning of a VR program
- No diagnoses of psychiatric disorders or cognitive impairment,
- Sign the informed consent
Exclusion Criteria:
- Who have suffered amputation in one of their lower limbs,
- History of neurological pathologies (stroke, multiple sclerosis, neuromuscular disease)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mini BESTest
Time Frame: 1 hour
|
Assessment scale of postural balance
|
1 hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
January 10, 2021
Primary Completion (ACTUAL)
May 1, 2022
Study Completion (ANTICIPATED)
May 1, 2024
Study Registration Dates
First Submitted
August 28, 2022
First Submitted That Met QC Criteria
August 28, 2022
First Posted (ACTUAL)
August 31, 2022
Study Record Updates
Last Update Posted (ACTUAL)
August 31, 2022
Last Update Submitted That Met QC Criteria
August 28, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5884
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vestibular Disease
-
Université Catholique de LouvainCompletedVestibular Disease | Vestibular DysfunctionUnited States, Belgium, France
-
Istanbul Medipol University HospitalCompletedVestibular Disease | Vestibular RehabilitationTurkey
-
Université Catholique de LouvainCompletedVestibular Disease | Vestibular Function DisorderBelgium
-
Istanbul Gelisim UniversityCompletedUnilateral Vestibular Dysfunction DiseaseTurkey
-
Combined Military Hospital QuettaRecruitingVestibular Disorder PreservationPakistan
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada
-
University of the Basque Country (UPV/EHU)BioarabaRecruitingVestibular Disease | Vestibular Disorder | Vestibular VertigoSpain
-
Groupe Hospitalier Paris Saint JosephCompletedEmergencies | Acute Vestibular SyndromeFrance
-
Medipol UniversityIstanbul Medeniyet UniversityCompletedRehabilitation | Vestibular Hypofunction | Vestibulopathy | Vestibular Exercises | Vestibular Assessment | Unilateral Vestibular DeficitTurkey (Türkiye)
-
University of RochesterNational Institute on Deafness and Other Communication Disorders (NIDCD)Recruiting
Clinical Trials on Assessment scale
-
Nanjing Medical UniversityCompleted
-
CelgeneCompletedMyelodysplastic Syndromes | Multiple Myeloma | Leukemia Myeloid Acute | Leuklemia, Lymphocytic, ChronicSpain
-
Gazi UniversityCompletedChild Development | Physical Disability | Participation, PatientTurkey
-
University Hospital, BordeauxCompleted
-
Our Lady's Hospice and Care ServicesCompleted
-
Izmir Katip Celebi UniversityCompletedHemiplegia, SpasticTurkey
-
Groupe Hospitalier de la Region de Mulhouse et...CompletedMajor Neurocognitive DisorderFrance
-
CHRISTUS HealthActive, not recruitingCough | Hypoxemia | Shortness of Breath | Respiratory Symptoms | Difficulty BreathingUnited States
-
Jessa HospitalCompletedScar | Minimally Invasive Cardiac SurgeryBelgium
-
Cairo UniversityRecruiting